期刊文献+

脂联素与2型糖尿病及糖尿病早期肾病的相关性分析 被引量:8

下载PDF
导出
摘要 目的分析血清脂联素与2型糖尿病(T2DM)及糖尿病肾病(DN)早期发生、发展的关系。方法采用酶联免疫吸附试验(ELISA)检测30例单纯T2DM患者,30例DN早期患者及30名健康对照者血清脂联素浓度,并作对比分析。结果单纯T2DM患者及DN早期组血清脂联素浓度明显低于健康对照组(P<0.01),DN早期组血清脂联素浓度明显低于单纯T2DM组(P<0.01)。结论血清脂联素浓度的降低可能与T2DM及DN的发生、发展有关。
出处 《检验医学》 CAS 北大核心 2011年第7期482-483,共2页 Laboratory Medicine
  • 相关文献

参考文献8

  • 1Scherer PE, Williams S, Fogliano M, et al. A novel serum protein similar to Clq, produced exclusively in adipocytes [ J ]. J Biol Chem, 1995,270 (45) : 26746-26749.
  • 2Fruebis J ,Tsao TS,Javorschi S, et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice [ J ]. Proc Natl Acad Sci USA, 2001, 98 (4) : 2005-2010.
  • 3蔡珂丹,闫蕾,孙子林,李玲,张晓良,刘必成.2型糖尿病肾病患者血清脂联素水平的变化[J].肾脏病与透析肾移植杂志,2009,18(1):39-43. 被引量:6
  • 4文洪林,邹文蓉,孟元,郭海,周梅,贺红.2型糖尿病肾病患者血清超敏C-反应蛋白、脂联素测定的临床意义[J].山西医科大学学报,2008,39(12):1121-1123. 被引量:2
  • 5Spranger J, Kroke A, Mtihig M, et al. Adiponectin and protection against type 2 diabetes mellitus I J] . Lancet , 2003 , 361 (9353) : 226-228.
  • 6Yang WS, Jeng CY, Wu TJ, et al. Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone increases plasma levels of adiponectin in type 2 diabetic patients [ J ] . Diabetes Care , 2002 , 25 (2) : 376-380.
  • 7Hotta K, Funahashi T, Bodkin NL, et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys[J]. Diabetes, 2001, 50 (5) : 1126-1133.
  • 8Daimon M, Oizumi T, Saitoh T, et al. Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population: the Funagata study [ J ]. Diabetes Care, 2003, 26 (7): 2015-2020.

二级参考文献31

  • 1马迎春,左力,王梅,周玉红,张春丽,徐国宾,王海燕.肾小球滤过率评估方程在慢性肾脏病不同分期中的适用性[J].中华内科杂志,2005,44(4):285-289. 被引量:82
  • 2袁国跃,周丽斌,唐金凤,杨颖,顾卫琼,李凤英,洪洁,顾燕云,徐敏,杜鹏飞,李小英,宁光,陈名道.糖耐量受损和2型糖尿病患者血清C反应蛋白与胰岛素敏感指数、脂联素的关系[J].中华内分泌代谢杂志,2005,21(6):507-510. 被引量:50
  • 3Yokota T, OrkaniK , Takahashi I, et al . Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages[J ]. Blood, 2000,96(5) : 1723 - 1732.
  • 4Lain KS, Xu A. Adiponectin: protection of the endothelium [ J ]. Curr Diab Rep,2005,5(4):254-259.
  • 5Joachim S, Anja K, Matthias M, et al. Aiponectin and protegtion against type 2 diabetes mellitus [J ]. Lancet, 2003, 361 (9358): 226 - 228.
  • 6Yang WS,Jeng CY ,Wu TJ, et al. Synthetic peroxisome proliferator-activated receptor-γagonist, rosiglitazone increase plasma levels of adionectin in type 2 diabetic patients [ J ]. Diabetes Care, 2002,25(2) :376 - 380.
  • 7OuchiN, Kihara S, AritaY, et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin [ J ]. Circulation, 1999,100 (25) :2473 - 2476.
  • 8Hotta K, funahashi T, Artita Y, et al. Plasma Concentrations of a Novel, Adipose-Specific Protein, Adiponectin, in Type 2 Diabetic Patients. Arterioscler Thromb Vasc Biol, 2000, 20 : 1595 - 1599.
  • 9Shibata R, Ouchi N, Kihara S, et al. Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of AMP-activated protein kinase signaling. Biol Chem ,2004,279:28670 - 28674.
  • 10Chen H, Montagnani M, Funahashi T, et al. Adiponectin stimulates production of nitric oxide in vascular enduthelial cells. Biol Chem, 2003,278:45021 -45026.

共引文献6

同被引文献147

引证文献8

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部